When People with Opioid-Induced Constipation Speak: A Patient Survey

被引:0
作者
Robert S. Epstein
J. Russell Teagarden
Ali Cimen
Mark Sostek
Tehseen Salimi
机构
[1] Epstein Health,
[2] AstraZeneca,undefined
[3] AstraZeneca,undefined
来源
Advances in Therapy | 2017年 / 34卷
关键词
Gastroenterology; Opioid-induced constipation; Pain; Patient survey; Quality of life;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:725 / 731
页数:6
相关论文
共 37 条
  • [1] Camilleri M(2014)Emerging treatments in neurogastroenterology: a multidisciplinary working group concensus statement on opioid-induced constipation Neurogastroenterology 26 1386-1395
  • [2] Drossman DA(2004)Opioid in chronic non-cancer pain: systematic review of efficacy and safety Pain 112 372-380
  • [3] Becker G(2013)Prevalence and impact of constipation and bowel dysfunction induced by strong opioids: a cross-sectional survey of 520 patient with cancer pain DYONISOS study J Med Econ 16 1423-1433
  • [4] Kalso E(2009)The prevalence, severity and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1) Pain Med 10 35-42
  • [5] Edwards JE(2014)Opioid-induced constipation in patient with chronic noncancer pain in the USA, Canada, Germany, and the UK: descriptive analysis of baseline patient-reported outcomes and retrospective chart review Clin Econ Outcome Res 6 269-281
  • [6] Moore RA(2015)Assessment of a stool symptom screener and understanding the opioid-induced constipation symptom experience Patient 8 317-327
  • [7] McQuay HJ(2009)Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: findings from the National Health and Wellness Survey J Opioid Manag 5 137-144
  • [8] Abramowitz L(2010)Costs of gastrointestinal events after outpatient opioid treatment for non-cancer pain Ann Pharmacother 44 630-640
  • [9] Béziaud N(2014)Patient preferences for change in symptoms associated with opioid-induced constipation Adv Ther 31 1263-1271
  • [10] Labreze N(2016)The burden of opioid-induced constipation: discordance between patient and health care provider reports J Manag Care Spec Pharm 22 236-245